Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 204.5 | 152.0 | 107.5 | 0.0 | 174.2 |
| Revenue growth | 34.6% | 41.3% | | -100.0% | |
| Cost of goods sold | 195.4 | 194.7 | 90.4 | 0.8 | 153.4 |
| Gross profit | 9.1 | -42.7 | 17.1 | -0.8 | 20.8 |
| Gross margin | 4.4% | -28.1% | 15.9% | | 12.0% |
| Selling, general and administrative | | | | 0.0 | |
| Sales and marketing | 15.9 | 15.4 | 13.8 | 0.0 | 13.4 |
| Research and development | 43.5 | 34.4 | 16.6 | | 32.4 |
| General and administrative | 37.3 | 42.1 | 18.8 | 0.0 | 34.2 |
| EBIT | -159.0 | -191.6 | -29.1 | -0.8 | -49.7 |
| EBIT margin | -77.7% | -126.1% | -27.1% | | -28.5% |
| Pre-tax income | -158.2 | -206.5 | -33.6 | 4.3 | -54.3 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.9 | 6.4 |
| Tax rate | | 0.0% | | 21.0% | |
| Net income | -158.2 | -206.5 | -33.6 | 3.4 | -54.9 |
| Net margin | -77.4% | -135.9% | -31.3% | | -31.5% |
| |
| Diluted EPS | ($0.52) | ($1.11) | ($0.34) | $0.42 | ($0.55) |
| Shares outstanding (diluted) | 303.3 | 185.9 | 99.0 | 7.9 | 99.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|